George Frey | Bloomberg | Getty Images Weight loss drugs exploded into the public eye this year, and 2024 will bring more
Tag: Altimmune Inc
Where M&A could be heading in the obesity drug space
Investors are contemplating where and when the next big obesity drug deal will occur. At the moment, Novo Nordisk and Eli Lilly
Apple, Amazon, Tesla, Chipotle, United
Here are Thursday’s biggest calls on Wall Street: Piper Sandler downgrades G-III to neutral from overweight Piper said in its downgrade of
No More Posts Available.
No more pages to load.